Welcome to our dedicated page for AptarGroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on AptarGroup stock.
AptarGroup, Inc. (ATR) is a global leader in providing a broad range of innovative dispensing systems for various markets, including beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage. Headquartered in Crystal Lake, Illinois, AptarGroup leverages its extensive manufacturing facilities across North America, Europe, Asia, and South America to serve customers worldwide.
Aptar's product portfolio includes aerosol valves, pumps, closures, and elastomer packaging components. The company operates through three primary business segments: Pharma, Beauty, and Closures. The Pharma division, which is the most significant contributor, is responsible for over two-thirds of the group's profits. The Beauty and Closures segments also play crucial roles in the company’s overall market strategy and revenue generation.
With the majority of its annual net sales stemming from Europe (50%) and the United States (33%), AptarGroup has been focusing on expanding its market presence in Asia (10%) and Latin America (7%). The company continually invests in research and development to maintain its competitive edge and deliver cutting-edge solutions to its clients.
Recent achievements for AptarGroup include strategic partnerships and product innovations that align with their commitment to sustainability and consumer satisfaction. The company continues to develop new dispensing technologies that are both eco-friendly and efficient, addressing the growing demand for sustainable packaging solutions.
For more detailed information about their products and services, visit their official website at www.aptar.com. Stay updated with AptarGroup’s latest developments and financial performance by following their news releases.
AptarGroup, Inc. (NYSE: ATR) announced that its Unidose Liquid System is the delivery system approved for neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis. This marks the first worldwide regulatory approval for nasally-delivered epinephrine. Aptar's Unidose is a single-use, ready-to-use, one-step nasal delivery system that administers neffy during severe allergic reactions. The system's design promotes ease of use and adherence for patients and caregivers. Aptar Pharma Services supported the development process, helping to accelerate approval for this novel Combination Product submission.
AptarGroup, Inc. (NYSE: ATR) has announced the appointment of Daniel Ackerman as its new Chief Accounting Officer, effective August 1, 2024. Ackerman, who joined Aptar in 2015 as Vice President, Corporate Controller, has been praised for his exemplary leadership and role in the company's cost management initiatives. He will continue to lead all corporate finance and accounting functions, while also contributing to Aptar's long-term financial planning strategy.
Ackerman's background includes international experience in Latin America and Asia with The Goodyear Tire & Rubber Company, as well as previous work at KPMG. He is a Certified Public Accountant (CPA) with Bachelor of Science degrees in Accounting and Finance from the University of Akron.
AptarGroup, Inc. (NYSE: ATR) announced significant leadership changes in its finance department. Bob Kuhn, Executive Vice President and CFO since 2008, will retire at the end of 2024 after 37 years with the company. Vanessa Kanu, a finance veteran with over 25 years of experience, will become the new CFO on January 1, 2025.
Kuhn's tenure as CFO saw him lead Aptar's global financial and IT functions, as well as spearhead M&A activities. Kanu, who most recently served as CFO of TELUS International, brings extensive experience in financial reporting, global operations, and cost management. She will lead Aptar's global finance organization, including planning, treasury, tax, financial reporting, financial operations, and IT.
AptarGroup (NYSE:ATR) reported solid second quarter results for 2024, with reported sales increasing 2% and core sales growing 3%. The company's net income rose 9% to $90 million, driven by strong growth in proprietary drug delivery systems and margin improvement. Earnings per share increased 8% to $1.34, while adjusted EPS grew 12% to $1.37.
The Pharma segment led growth with a 6% increase in reported sales and 7% in core sales. Beauty and Closures segments saw slight declines. For the first six months of 2024, Aptar achieved double-digit earnings growth and strong net cash provided by operations. The company also increased its quarterly dividend by 10% to $0.45 per share.
AptarGroup, a leader in drug delivery and consumer product technologies, has announced a nearly 10% increase in its quarterly dividend to $0.45 per share. This elevates the annualized dividend to $1.80 per share, payable on August 15, 2024, to shareholders recorded by July 25, 2024. President and CEO Stephan B. Tanda highlighted the company's robust performance and future growth prospects as reasons for this increase. Over the past five years, Aptar has returned over $780 million to shareholders through dividends and share repurchases. This marks the 31st consecutive year of increasing annual dividends. Additionally, Aptar will discuss its Q2 2024 results during a conference call on July 26, 2024.
Aptar (NYSE: ATR), a leader in drug and consumer product technologies, has been named one of the World’s Most Sustainable Companies for 2024 by TIME. Ranked 194 out of 500 global companies, the selection process, conducted with Statista, evaluated over 5,000 companies on 20 key data points, including emissions, energy intensity, and safety. Aptar's sustainability achievements include receiving the prestigious EcoVadis Platinum rating for four consecutive years and being named a CDP Supplier Engagement Leader. Stephan B. Tanda, Aptar’s CEO, emphasized the company’s commitment to sustainable practices and its competitive advantage. Aptar aims for 10% recycled resin content and 100% recyclable, reusable, or compostable solutions by 2025.
Aptar, a global leader in drug delivery and consumer product dispensing technologies, has been named one of America's Climate Leaders 2024 by USA Today for the second consecutive year. The company has showcased significant advancements in sustainability, including a climate transition plan aligned with the latest climate science, and achieving 97% of its electricity consumption from renewable sources by the end of 2023. Additionally, Aptar has reduced its absolute Scope 1 and Scope 2 emissions by 77% since 2019, and has seen a year-over-year reduction in Scope 3 emissions. The company was also recognized among America’s Most Responsible Companies 2024 by Newsweek and one of Barron’s 100 Most Sustainable U.S. Companies. These achievements are highlighted in their 2023 Corporate Sustainability/ESG Report, which adheres to GRI Standards.
Aptar has released its 2023 Corporate Sustainability and ESG Report, titled Progress Takes Shape. The report outlines significant accomplishments in the company's sustainability strategy, focusing on three main pillars: Care, Collaboration, and Circularity.
Key achievements include sourcing 97% of electricity from renewable sources, preventing 86% of operational waste from reaching landfills, and obtaining Landfill Free Certification for 63% of its sites. Aptar has also earned the EcoVadis Platinum rating and the CDP Supplier Engagement Leader status for the fourth consecutive year.
Additionally, Aptar has partnered with organizations like the Ellen MacArthur Foundation and the World Business Council for Sustainable Development. The company's Diversity, Equity, and Inclusion (DEI) initiatives have led to 25.4% female leadership at the VP level and above, with a goal of reaching 30% by 2025.
Aptar continues to support communities through donations, local charitable events, and global campaigns for women's economic empowerment.
Aptar, a leader in drug and consumer product technologies, has achieved a Platinum rating from EcoVadis for the fourth consecutive year, placing it in the top 1% of more than 125,000 companies rated globally. This recognition highlights Aptar's commitment to sustainability, encompassing eco-efficient operations, renewable energy sourcing, and the development of recyclable and reusable products. The EcoVadis assessment evaluates companies on environment, labor and human rights, ethics, and sustainable procurement. Aptar integrates these principles into its Supplier Screening Program, enhancing transparency and continuous improvement. The firm's sustainability efforts are further recognized by affiliations with the United Nations Global Compact and the Ellen MacArthur Foundation.
FAQ
What is the current stock price of AptarGroup (ATR)?
What is the market cap of AptarGroup (ATR)?
What products does AptarGroup manufacture?
Where is AptarGroup headquartered?
In which markets does AptarGroup operate?
What are the main business segments of AptarGroup?
Where does AptarGroup generate most of its sales?
What percentage of AptarGroup's profits come from the Pharma division?
Is AptarGroup expanding in any specific regions?
How does AptarGroup contribute to sustainability?